Infectious Keratoconjunctivitis (sheep, goats)

Infectious keratoconjunctivitis in sheep and goats is a highly contagious ocular disease causing inflammation of the cornea and conjunctiva that can spread rapidly through flocks, resulting in significant welfare concerns and economic losses. The disease is caused primarily by Mycoplasma conjunctivae and Chlamydia psittaci, often acting in combination, and produces clinical signs ranging from mild conjunctival redness and tearing to severe corneal ulceration with potential for permanent blindness. The condition occurs worldwide wherever sheep and goats are raised and represents one of the most common and economically important eye diseases of small ruminants.

The disease affects both sheep and goats of all ages and breeds, though young animals and those encountering the causative organisms for the first time typically develop more severe clinical disease. Outbreaks commonly occur when susceptible animals are introduced to infected populations, during periods of stress such as weaning or transport, or when environmental conditions favor disease transmission. Close contact in housing situations, at feeding sites, or during handling facilitates the rapid spread that characterizes outbreaks. Flies serve as mechanical vectors, carrying organisms from infected to susceptible animals and contributing to summer disease peaks in many regions.

The economic impact of infectious keratoconjunctivitis in small ruminants includes direct treatment costs, labor for animal care, reduced productivity from pain and visual impairment, and potential permanent losses from blindness or death in severe cases. Affected animals show reduced feed intake, weight loss, decreased milk production in dairy operations, and impaired ability to care for offspring. Visually impaired animals may separate from flocks, fall prey to predators, or injure themselves navigating terrain they cannot see clearly. Permanent corneal scarring in recovered animals may reduce sale value, particularly for breeding stock.

Effective management of infectious keratoconjunctivitis combines prompt treatment of affected individuals with control measures targeting transmission routes and predisposing factors. Antibiotic therapy achieves high cure rates when initiated early in the disease course, while environmental management and fly control reduce disease spread within affected flocks. Recovery of useful vision occurs in most treated animals, though severe cases may retain permanent corneal opacity. Understanding the infectious nature of the disease and implementing appropriate biosecurity measures protects susceptible animals from exposure during outbreak situations.

The primary causative agents of infectious keratoconjunctivitis in sheep and goats are Mycoplasma conjunctivae and Chlamydia psittaci (specifically the ovis biovar), which may cause disease individually or as co-infections producing more severe clinical signs. Mycoplasma conjunctivae attaches to conjunctival and corneal epithelium, producing cytotoxic effects that damage these delicate tissues. Chlamydia psittaci causes similar epithelial damage through its unique intracellular lifecycle, replicating within host cells and destroying them upon release of new infectious particles. When both organisms infect simultaneously, synergistic effects often produce more rapid disease progression and more extensive corneal damage than either agent alone.

Environmental factors play crucial roles in disease occurrence and severity beyond the presence of causative organisms. Ultraviolet light exposure damages corneal epithelium, creating susceptible surfaces for bacterial attachment and infection establishment. Dust, plant materials, and other physical irritants cause similar corneal microtrauma that predisposes to infection. Close housing conditions during winter or during management procedures increase contact transmission rates. Flies serve as mechanical vectors, carrying infectious organisms on their mouthparts from infected eyes to susceptible animals. Seasonal patterns reflect the interaction of these environmental factors with organism prevalence in the population.

Stress from any cause increases susceptibility to infectious keratoconjunctivitis through immunosuppressive effects that compromise ocular defense mechanisms. Transportation stress, particularly during auction and commingling events, precedes many outbreaks as stressed animals encounter unfamiliar organisms. Weaning stress in lambs and kids increases disease susceptibility during this already challenging transition period. Nutritional stress from inadequate feed quality or quantity compromises immune function. Concurrent disease including parasitism and respiratory infections diverts immune resources and increases vulnerability to ocular infection.

Risk factors for infectious keratoconjunctivitis include age, immune status, flock dynamics, and management intensity. Young stock and animals new to a flock lack immunity from previous exposure and develop more severe disease than previously infected adults. Commingling animals from multiple sources introduces diverse organisms and exposes immunologically naive individuals. Intensive housing systems with high stocking density facilitate transmission. Poor ventilation allows airborne organism concentrations to build. Inadequate fly control permits vector transmission to continue unabated.

The pathophysiology of infection involves organism attachment to epithelial surfaces followed by cell damage and inflammatory responses. Mycoplasma conjunctivae adheres to conjunctival and corneal epithelial cells through specialized surface structures, producing membrane-damaging cytotoxins that cause cell death. Chlamydia enters epithelial cells, replicates extensively, then ruptures cells during release of new infectious bodies. The combined effects of direct cell damage and inflammatory responses produce the characteristic conjunctival hyperemia, corneal opacity, and exudative discharge. Progressive corneal involvement can lead to ulceration, and secondary bacterial infection may complicate primary Mycoplasma or Chlamydia disease.

Early warning signs of infectious keratoconjunctivitis in sheep and goats include increased tearing and subtle behavioral changes indicating ocular discomfort. Affected animals show serous ocular discharge that wets the facial wool or hair below the eye. Mild squinting and light avoidance behaviors appear as photophobia develops from corneal irritation. The conjunctival membranes appear reddened when examined closely. Animals may rub their faces against fencing, feeders, or other objects seeking relief from the irritation. These early signs often progress rapidly within 24 to 48 hours to more obvious disease manifestations.

Common symptoms of established infectious keratoconjunctivitis include obvious ocular discharge, pronounced squinting or complete eyelid closure, and visible corneal cloudiness. The discharge becomes mucopurulent as disease progresses, accumulating at the medial corner of the eye and matting facial wool or hair. Corneal opacity begins as subtle haziness but progresses to dense white or blue-gray discoloration as edema and cellular infiltration increase. The conjunctiva appears intensely reddened and swollen. Both eyes commonly become affected, either simultaneously or with the second eye developing signs within days of the first.

Behavioral changes in animals with infectious keratoconjunctivitis reflect pain, visual impairment, and attempts to avoid further irritation. Affected animals separate from the flock, standing alone or seeking dark, protected areas away from bright light and fly activity. Feed intake declines markedly, both from pain-related appetite suppression and difficulty locating feed when vision is impaired. Water intake may similarly decrease. Animals with bilateral disease become disoriented, reluctant to move, and may walk into obstacles or fail to avoid hazards they would normally evade. Nursing lambs or kids with bilateral involvement may have difficulty locating their dams.

Physical examination findings vary with disease stage and severity. Mild cases show conjunctival hyperemia, serous discharge, and subtle corneal cloudiness without ulceration. Moderate disease presents with mucopurulent discharge, pronounced corneal opacity, and visible blood vessel ingrowth from the limbus toward the central cornea. Severe cases develop corneal ulceration visible as irregular depressions or craters in the corneal surface, sometimes with yellow fibrinous material adherent to ulcer beds. The most severe presentations show deep ulcers with descemetocele formation or actual perforation with iris prolapse.

Symptom progression without treatment follows a pattern of increasing corneal involvement and potential complications. Early conjunctivitis advances to involve the cornea within days if untreated. Corneal opacity deepens and expands as inflammation intensifies. Ulceration develops in more severe cases, creating risk for secondary bacterial infection and accelerated tissue destruction. Deep ulcers may perforate, allowing aqueous humor to leak and potentially permitting iris tissue to prolapse through the corneal defect. Even with eventual spontaneous resolution, untreated disease frequently leaves permanent corneal scarring affecting vision.

Emergency symptoms requiring immediate veterinary attention include evidence of corneal perforation such as altered anterior chamber depth, visible iris tissue at the corneal surface, or clear fluid discharge suggesting aqueous humor leakage. Deep ulcers with thin, bulging floors indicating descemetocele formation represent impending perforation requiring urgent intervention. Complete bilateral blindness in valuable animals warrants aggressive treatment to salvage any remaining visual potential. Systemic illness accompanying eye disease suggests complications beyond routine infectious keratoconjunctivitis.

Clinical diagnosis of infectious keratoconjunctivitis relies on recognition of characteristic ocular signs in the context of flock epidemiology suggesting contagious disease. The combination of conjunctival hyperemia, ocular discharge, and corneal opacity in multiple animals within a group strongly suggests infectious keratoconjunctivitis. Examination of affected individuals determines disease severity and guides treatment decisions. Assessment of the number and distribution of cases within the flock indicates outbreak extent and informs control strategy development. The highly contagious nature means that identification of initial cases should prompt examination of all flock members.

Diagnostic laboratory tests can confirm causative organisms when definitive diagnosis is needed or when treatment failures prompt investigation of potential alternative causes or antimicrobial resistance. Conjunctival swabs submitted for Mycoplasma culture or polymerase chain reaction testing detect M. conjunctivae infection. Chlamydia detection uses similar sampling with specific culture techniques or molecular diagnostics. Combined testing for both organisms provides complete diagnostic information for complex cases. Antibiotic sensitivity testing guides treatment selection when resistance is suspected, though empirical therapy based on clinical diagnosis remains appropriate for most field situations.

Differential diagnosis for sheep and goats presenting with ocular discharge and corneal opacity includes other infectious, parasitic, and traumatic conditions affecting the eye. Entropion in lambs causes corneal damage from eyelid malposition rather than infection. Foreign bodies produce localized corneal lesions potentially mistaken for focal infection. Listeriosis may include ocular manifestations as part of neurological disease. Thelazia eyeworm infection causes chronic conjunctivitis resembling bacterial disease. Trauma produces acute corneal damage requiring differentiation from infection. Examination for specific characteristics of each condition enables accurate diagnosis.

Herd-level diagnostic evaluation characterizes outbreak extent and identifies risk factors amenable to management intervention. Determination of attack rates across different animal groups identifies particularly susceptible populations. Assessment of housing conditions, fly pressure, and recent management events identifies predisposing factors for the current outbreak. Review of introduction history suggests potential sources of new organism strains. Collection of diagnostic samples from multiple affected animals provides comprehensive information about circulating pathogens. This epidemiological assessment informs both immediate treatment decisions and long-term prevention planning.

Emergency treatment for severe infectious keratoconjunctivitis aims to prevent corneal perforation while controlling infection and managing pain. Temporary third eyelid flaps or tarsorrhaphy sutures protect deeply ulcerated corneas from mechanical trauma during healing. Subconjunctival antibiotic injection provides sustained high concentrations directly at the infection site. Systemic anti-inflammatory medications control pain and reduce destructive inflammatory responses. Animals with bilateral severe disease and complete visual impairment require supportive care including guidance to feed and water until vision recovers. These intensive interventions are typically reserved for valuable individuals with severe disease.

Medical management of infectious keratoconjunctivitis relies primarily on systemic antibiotic therapy targeting the causative organisms. Long-acting oxytetracycline provides effective coverage against both Mycoplasma and Chlamydia and represents the most commonly used treatment. Single injection of long-acting formulation achieves therapeutic levels for approximately 72 hours. Florfenicol offers an alternative with excellent efficacy against ocular pathogens. Tulathromycin provides extended activity from single-dose administration. Early treatment before significant corneal damage produces best outcomes with rapid resolution of clinical signs in most cases. All treatments must be documented with appropriate withdrawal time observation for food animals.

Topical therapy applied directly to affected eyes supplements systemic treatment in individual animal management situations. Ophthalmic antibiotic ointments containing oxytetracycline or chlortetracycline provide direct antimicrobial activity at the infection site. Application two to three times daily maintains effective drug levels on the ocular surface. Topical treatment requires more labor than single systemic injections, making it practical primarily for small numbers of valuable animals or severe cases. Atropine ophthalmic ointment provides pain relief through ciliary muscle relaxation in animals with significant corneal involvement.

Supportive care optimizes healing conditions and maintains animal welfare during the recovery period. Moving affected animals to shaded areas reduces UV exposure that exacerbates corneal damage. Fly control using topical or systemic products decreases vector transmission and reduces irritation from fly feeding activity around eyes. Ensuring adequate feed and water access prevents secondary malnutrition in animals with impaired vision. Separation of severely affected individuals from the main flock prevents transmission while providing a protected environment for recovery.

Flock treatment protocols address outbreak situations efficiently when many animals require treatment. Systematic examination of all flock members identifies affected individuals for treatment. Mass treatment of the entire flock may be justified during explosive outbreaks with high attack rates, providing both therapeutic and prophylactic coverage. Strategic treatment timing at handling events combines eye examination with other scheduled procedures. Treatment records document medications administered for withdrawal time compliance and enable outcome analysis for protocol evaluation.

Treatment decisions consider disease severity, individual animal value, and practical constraints when determining management approach. Mild cases in commercial animals may be monitored for spontaneous recovery or treated with single-injection protocols. Severe cases in valuable breeding stock warrant more intensive intervention including protective surgery and frequent topical treatment. Animals with irreversible corneal damage face decisions about salvage marketing versus continued treatment. Economic analysis of treatment costs against likely outcomes and animal values guides rational decision-making while maintaining appropriate welfare standards.

Recovery timeline for infectious keratoconjunctivitis depends on disease severity at treatment initiation and response to therapy. Mild cases treated early show clinical improvement within two to three days, with complete resolution of discharge and corneal clearing over one to two weeks. Moderate cases with established corneal opacity require two to four weeks for healing, with gradual reduction in opacity continuing for several additional weeks. Severe cases with ulceration need four to eight weeks for complete healing and may retain permanent corneal scarring. Full return of normal corneal clarity following significant disease may take two to three months.

Post-treatment monitoring confirms therapeutic response and identifies cases requiring additional intervention. Examination at 48 to 72 hours after treatment initiation should demonstrate improvement in discharge amount and character. Failure to improve suggests need for alternative antibiotic selection or investigation of complicating factors. Weekly monitoring during the healing phase documents progressive corneal clearing. Fluorescein staining at follow-up examinations confirms epithelial healing over ulcerated areas. Persistent signs despite appropriate treatment warrant diagnostic sample collection for organism identification and sensitivity testing.

Prognostic factors influencing recovery outcomes include corneal damage extent, ulcer depth and location, and treatment timing. Animals treated before ulceration develops carry excellent prognosis for complete recovery without permanent visual impairment. Central corneal lesions affecting the visual axis have greater functional impact than peripheral damage. Deep ulcers, particularly those approaching or involving Descemet's membrane, frequently result in permanent scarring. Young animals generally demonstrate faster and more complete healing than older individuals. Good nutritional status and absence of concurrent disease support optimal recovery.

Return to production following infectious keratoconjunctivitis proceeds normally for most recovered animals. Unilateral visual impairment from corneal scarring is well-tolerated by sheep and goats in typical production settings. Animals recovering useful vision in both eyes show no lasting production effects. Recovered animals develop immunity that provides some protection against future infection, though reinfection can occur with exposure to different organism strains or after immunity wanes. Documented withdrawal times from antibiotic treatment must elapse before animals can be marketed for slaughter.

Vaccination options for infectious keratoconjunctivitis in sheep and goats are limited compared to cattle pinkeye vaccines, though some products are available in certain regions. Commercial Mycoplasma conjunctivae vaccines exist in Europe and may reduce disease severity in vaccinated animals. Autogenous vaccines prepared from organisms isolated from affected flocks may provide targeted protection. Vaccination timing should precede anticipated disease risk periods by two to four weeks to allow immunity development. The variable efficacy of available vaccines means that vaccination should complement rather than replace other prevention measures.

Biosecurity measures provide important protection against introducing infectious keratoconjunctivitis to susceptible flocks. Quarantine of newly purchased animals for two to three weeks allows development of any incubating disease before contact with resident stock. Observation of quarantined animals for ocular abnormalities enables early detection and treatment of infected individuals. Avoiding purchase of animals with visible eye problems or from flocks with known disease history reduces introduction risk. Maintaining closed flocks when practical eliminates the primary route of disease introduction.

Nutritional management supports ocular health and immune function that resists infection. Adequate vitamin A nutrition maintains healthy conjunctival and corneal epithelium that resists organism attachment. Trace mineral supplementation supports immune responses and tissue integrity. Overall nutrition programs that maintain body condition provide resources for effective disease resistance. Avoiding nutritional stress that compromises immunity reduces susceptibility when organism exposure occurs.

Management practices addressing environmental risk factors substantially reduce infectious keratoconjunctivitis incidence. Fly control through environmental management and insecticide application reduces mechanical transmission of causative organisms. Reducing overcrowding decreases contact transmission opportunities. Providing adequate ventilation in housing prevents buildup of airborne organism concentrations. Dust control reduces corneal microtrauma that predisposes to infection. Providing shade decreases UV-induced corneal damage. These environmental modifications create conditions less favorable for disease establishment and spread.

Quarantine and isolation protocols contain disease spread during outbreak situations. Prompt isolation of affected animals from uninfected flockmates reduces transmission through direct contact and fly vectors. Handling affected animals last during routine procedures prevents mechanical transmission on equipment or handler clothing. Treating all contact animals in outbreak groups addresses subclinical infections that might otherwise perpetuate transmission. These containment measures complement treatment efforts to control ongoing outbreaks.

Daily management during disease risk periods emphasizes early detection through vigilant observation. Personnel should examine animals for tearing, squinting, and facial soiling during routine activities including feeding and pen checking. Close observation when animals are gathered for other purposes provides opportunity for thorough eye examination. Any animals showing early signs should be segregated for examination and treatment. Recording observed cases supports epidemiological assessment and treatment outcome tracking. Training all animal handlers in disease recognition maximizes detection efficiency.

Housing and environmental management creates conditions that minimize disease risk through multiple mechanisms. Adequate space allocation reduces animal density and associated contact transmission. Ventilation systems maintain air quality while avoiding direct drafts on animal eyes. Fly control within housing includes elimination of breeding sites, physical exclusion, and chemical control methods. Lighting design provides adequate illumination for observation while avoiding intense direct light that causes squinting. Bedding management maintains clean, relatively dust-free resting areas.

Herd health programs integrate infectious keratoconjunctivitis prevention and management into comprehensive flock health planning. Annual health plans include vaccination if available, fly control programs, and environmental assessments. Treatment protocols establish consistent responses when disease occurs. Veterinary consultation provides expertise for outbreak investigation and management optimization. Economic analysis of prevention investments guides resource allocation across competing health priorities.

Record keeping systems track disease incidence and treatment outcomes to support program evaluation and improvement. Case records document date, animal identification, severity, treatment provided, and outcome for each affected individual. Aggregate tracking monitors incidence rates by season, animal group, and management unit. Treatment outcome analysis identifies effective protocols and detects emerging resistance. Long-term data enables trend analysis and correlation of disease incidence with management changes.

Economic considerations influence prevention and treatment investments based on expected returns and practical constraints. Prevention programs require ongoing investment in fly control, environmental management, and vaccination that should be evaluated against historical disease losses. Treatment costs for individual animals remain relatively modest, favoring intervention for affected animals. Production losses from disease including reduced growth, decreased milk production, and marketing impacts often exceed direct treatment costs substantially. Permanent visual impairment may reduce breeding stock value. Comprehensive economic assessment supports rational resource allocation for infectious keratoconjunctivitis management.

No specific sheep or goat breeds demonstrate markedly increased susceptibility to infectious keratoconjunctivitis based on inherent genetic factors. Unlike cattle pinkeye where periocular pigmentation strongly influences risk, small ruminant infectious keratoconjunctivitis affects all breeds with similar frequency when exposed to causative organisms under comparable conditions. Disease incidence patterns primarily reflect management factors, environmental conditions, and organism exposure rather than breed genetics. All breeds should be considered susceptible and appropriate prevention measures implemented regardless of flock composition.

Production type considerations reveal disease patterns associated with different management systems more than breed differences. Intensive housing systems experience outbreaks when organisms are introduced due to close contact facilitating transmission. Extensive grazing systems may have lower transmission rates but face challenges in early detection and treatment of affected individuals. Show flocks with frequent animal movement and commingling face elevated exposure risks. Dairy flocks with frequent handling for milking have opportunities for observation but also potential for mechanical transmission during procedures.

Genetic selection strategies have limited application to infectious keratoconjunctivitis given the absence of breed-specific susceptibility differences. No genetic markers for disease resistance have been identified that would enable selection. Individual variation in immune responses may affect disease severity, but heritability of such variation has not been characterized for small ruminant keratoconjunctivitis. Selection programs focused on general disease resistance and vigor may provide indirect benefits. Management modification and environmental control offer more practical approaches to disease control than genetic strategies for this condition.

Commonly co-occurring conditions with infectious keratoconjunctivitis include concurrent infections and stress-related diseases affecting small ruminants. Respiratory diseases including pneumonia may accompany eye infections, particularly when both result from stress-induced immunosuppression. Parasitism weakens immune responses and may predispose to ocular infection or worsen disease severity. Other stress-related conditions including pregnancy toxemia in late-gestation ewes may occur in the same animals or flocks experiencing keratoconjunctivitis outbreaks. Management of concurrent conditions supports recovery from eye disease.

Conditions producing similar symptoms to infectious keratoconjunctivitis require differentiation for appropriate treatment. Entropion in lambs causes corneal damage and discharge from mechanical rather than infectious causes. Foreign bodies produce localized corneal lesions mimicking focal infection. Trauma causes acute corneal damage potentially confused with early infectious disease. Listeriosis manifests neurological signs that may include abnormal eye appearance. Photosensitization affecting periocular skin produces swelling and discharge distinct from primary eye infection. Careful examination distinguishes these conditions from infectious keratoconjunctivitis.

Complications and sequelae of infectious keratoconjunctivitis primarily involve permanent corneal damage from severe or inadequately treated disease. Corneal scarring persists after healing, causing variable degrees of permanent visual impairment depending on lesion location and extent. Deep ulceration may progress to perforation with iris prolapse, resulting in permanent blindness in the affected eye. Secondary bacterial infection complicates some cases, potentially causing more severe tissue destruction than primary Mycoplasma or Chlamydia infection alone. Panophthalmitis from spread of infection to internal eye structures carries poor prognosis and may require enucleation.